 PLANO, Texas--BUSINESS WIRE--Reata Pharmaceuticals, Inc. Nasdaq: RETA Reata, the Company, or we, a clinical-stage biopharmaceutical company, today announced that abstracts highlighting clinical data for bardoxolone methyl bardoxolone and disease education data on Alport syndrome will be presented at the American Society of Nephrology Kidney Week 2021 being held virtually from November 4 7, 2021. The abstracts for the oral and poster presentations are listed below and are avail 